Bank of New York Mellon Corp - PRINCIPIA BIOPHARMA INC ownership

PRINCIPIA BIOPHARMA INC's ticker is PRNB and the CUSIP is 74257L108. A total of 74 filers reported holding PRINCIPIA BIOPHARMA INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of PRINCIPIA BIOPHARMA INC
ValueSharesWeighting
Q2 2020$6,473,000
+17.3%
108,266
+16.5%
0.00%0.0%
Q1 2020$5,518,000
+19.5%
92,922
+10.2%
0.00%
+100.0%
Q4 2019$4,619,000
+266.3%
84,306
+88.8%
0.00%
Q3 2019$1,261,000
-15.6%
44,661
-0.7%
0.00%
Q2 2019$1,494,000
+132.7%
44,996
+138.0%
0.00%
Q1 2019$642,00018,9090.00%
Other shareholders
PRINCIPIA BIOPHARMA INC shareholders Q2 2019
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 401,046$23,814,00013.70%
BVF INC/IL 1,583,595$94,034,0008.76%
Sofinnova Investments, Inc. 1,417,258$84,157,0007.78%
New Leaf Venture Partners, L.L.C. 422,214$25,071,0007.50%
Cormorant Asset Management, LP 2,100,000$124,698,0005.79%
Redmile Group, LLC 2,261,088$134,263,0003.76%
Consonance Capital Management LP 689,718$40,955,0003.05%
EAM Global Investors LLC 43,369$2,575,0001.51%
EAM Investors, LLC 61,831$3,672,0001.14%
Woodline Partners LP 242,776$14,416,0001.03%
View complete list of PRINCIPIA BIOPHARMA INC shareholders